SCHEMBL10183321

SCHEMBL10183321

O=C1C(N(C(=O)Cc2ccc(O)cc2)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 2/20 0.37
▸ OPRK1 P41145 2/20 0.37
▸ OPRL1 P41146 2/20 0.37
▸ LTB4R2 Q9NPC1 1/20 0.36
▸ CCKBR P32239 3/20 0.34
▸ CCKAR P32238 2/20 0.34
▸ AGTR2 P50052 1/20 0.34
▸ IDH1 O75874 2/20 0.34
▸ CCR5 P51681 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ NR1H4 Q96RI1 1/20 0.33
▸ NPC1L1 Q9UHC9 1/20 0.33
▸ KCNQ2 O43526 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10184034 0.88 CCKBR (0.36) OPRM1OPRK1OPRL1CCKBRAGTR2
SCHEMBL10183329 0.88 CCKBR (0.36) OPRM1OPRK1OPRL1CCKBRAGTR2
SCHEMBL10183299 0.87 OPRM1 (0.40) OPRM1OPRK1OPRL1CCKBRCCKAR
SCHEMBL10183802 0.86 OPRM1 (0.38) OPRM1OPRK1OPRL1CCKBRCCKAR
SCHEMBL10185957 0.86 TSHR (0.43) OPRM1OPRK1OPRL1IDH1KMT2A
SCHEMBL10183337 0.86 OPRM1 (0.39) OPRM1OPRK1OPRL1CCKBRCCKAR
SCHEMBL10183319 0.86 MEN1 (0.43) OPRM1OPRK1OPRL1CCKBRCCKAR
SCHEMBL10185857 0.86 SLC6A2 (0.38) OPRM1OPRK1OPRL1MAPT
SCHEMBL10183638 0.85 OPRM1 (0.35) OPRM1OPRK1OPRL1CCKBRCCKAR
SCHEMBL10183666 0.84 OPRM1 (0.39) OPRM1OPRK1OPRL1AGTR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback